You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 21, 2025

Details for Patent: 4,800,079


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 4,800,079
Title: Medicine based on fenofibrate, and a method of preparing it
Abstract:A granular medicine based on fenofibrate, each granule comprising an inert core, a layer based on fenofibrate, and a protective layer, the medicine being characterized in that the fenofibrate in the layer based on fenofibrate is present in the form of crystalline microparticles of dimensions not greater than 30 microns, and preferably less than 10 microns.
Inventor(s): Boyer; Jean-Francois (78550 Houdan, FR)
Assignee:
Application Number:07/083,409
Patent Claim Types:
see list of patent claims
Formulation; Compound; Composition;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 4,800,079

Introduction

Patents are crucial for protecting intellectual property and driving innovation. To fully appreciate the value and impact of a patent, it is essential to analyze its scope, claims, and the broader patent landscape. This article will delve into the specifics of United States Patent 4,800,079, focusing on its scope, claims, and the context within which it exists.

Overview of United States Patent 4,800,079

United States Patent 4,800,079, titled "Oral Dosage Forms Comprising Fenofibrate," was granted for a specific formulation of fenofibrate, a medication used to treat high cholesterol and other lipid disorders.

Scope of the Patent

Definition of Patent Scope

The scope of a patent is defined by its claims, which outline the specific invention and its boundaries. The scope determines what is protected under the patent and what is not[3].

Claims Analysis

For Patent 4,800,079, the claims are centered around the formulation of fenofibrate in oral dosage forms. Here are some key aspects:

  • Independent Claims: These claims stand alone and define the invention without reference to other claims. In this patent, the independent claims describe the specific composition of the oral dosage form, including the presence of fenofibrate, a phospholipid, a buffer salt, and a water-soluble bulking agent[5].
  • Dependent Claims: These claims refer back to and further limit the independent claims. They often provide additional details or variations of the invention. For example, dependent claims might specify different ratios of the components or additional ingredients that can be included in the formulation.

Metrics for Measuring Patent Scope

Independent Claim Length and Count

Research has shown that the length and count of independent claims can be useful metrics for measuring patent scope. Patents with narrower claims (shorter length and fewer claims) tend to have a higher probability of grant and a shorter examination process compared to those with broader claims[3].

Application to Patent 4,800,079

While the specific metrics for Patent 4,800,079 are not provided here, analyzing the claim length and count can give insights into the patent's scope. Generally, patents with more focused claims are less likely to face challenges during the examination process.

Patent Examination Process

Impact on Patent Scope

The patent examination process can significantly affect the scope of a patent. During this process, the claims may be narrowed to ensure they are novel, non-obvious, and fully described. This narrowing can result in a more defined and defensible patent scope[3].

Example from Patent 4,800,079

If the original claims in Patent 4,800,079 were broad, the examination process might have required the inventors to narrow these claims to avoid prior art or to clarify the invention. This would result in a more precise definition of what is protected under the patent.

Patent Landscape

Related Patents and Prior Art

The patent landscape for fenofibrate formulations includes several other patents that describe different aspects of fenofibrate preparation and use. For instance, other patents like U.S. Pat. No. 4,058,552 and U.S. Pat. No. 4,800,079 are cited in the literature as related to fenofibrate formulations[5].

Global Patent System

The global patent system, facilitated by tools like the Global Dossier and Common Citation Document (CCD), allows for the tracking of related applications and prior art across different intellectual property offices. This helps in understanding the broader context in which Patent 4,800,079 exists and how it interacts with other patents in the field[4].

Valuation of Patents

Methods of Valuation

Patents can be valued using the cost, income, and market approaches. The cost approach considers the development cost of the patent, the income approach looks at future benefits, and the market approach considers what a willing buyer would pay for a similar asset[1].

Example Valuations

While the specific valuation of Patent 4,800,079 is not publicly available, similar patents in the pharmaceutical sector can command significant prices. For instance, the sale of patent portfolios involving pharmaceuticals can range from hundreds of thousands to millions of dollars per document[1].

Practical Implications

Licensing and Litigation

The scope and claims of a patent like 4,800,079 have significant practical implications. A well-defined scope can help in licensing negotiations and reduce the risk of litigation. Narrower claims that are clearly defined can make it easier to enforce the patent and avoid disputes over infringement[3].

Innovation Incentives

The clarity and validity of patent claims also impact innovation incentives. Patents with clear and valid claims provide a stronger incentive for innovation by offering clear protection for inventors and reducing the costs associated with licensing and litigation[3].

Key Takeaways

  • Patent Scope: Defined by the claims, which outline the specific invention and its boundaries.
  • Claims Analysis: Independent and dependent claims define the invention and its variations.
  • Patent Examination: The process can narrow the claims to ensure novelty, non-obviousness, and full description.
  • Patent Landscape: Understanding related patents and prior art is crucial for navigating the intellectual property landscape.
  • Valuation: Patents can be valued using cost, income, and market approaches.
  • Practical Implications: Clear and valid claims impact licensing, litigation, and innovation incentives.

FAQs

What is the primary focus of United States Patent 4,800,079?

The primary focus of United States Patent 4,800,079 is the formulation of fenofibrate in oral dosage forms, including the specific composition and components.

How are patent claims analyzed?

Patent claims are analyzed by examining the independent and dependent claims, which define the invention and its boundaries. Metrics such as claim length and count can also provide insights into the patent's scope.

What is the impact of the patent examination process on patent scope?

The patent examination process can narrow the claims to ensure they are novel, non-obvious, and fully described, resulting in a more defined and defensible patent scope.

How is the value of a patent determined?

The value of a patent can be determined using the cost, income, and market approaches. Each method considers different aspects such as development costs, future benefits, and market prices for similar assets.

Why is the clarity of patent claims important?

The clarity of patent claims is important because it affects licensing negotiations, litigation risks, and innovation incentives. Clear and valid claims provide stronger protection for inventors and reduce costs associated with licensing and litigation.

Where can I find more information about related patents and prior art?

You can find more information about related patents and prior art using tools like the Global Dossier, Common Citation Document (CCD), and databases provided by intellectual property offices such as the USPTO, EPO, and WIPO[4].

Sources

  1. The Value of a Patent - Perpetual Motion Patents
  2. EP1517676A1 - Oral dosage forms comprising ... - Google Patents
  3. Patent Claims and Patent Scope - SSRN
  4. Search for Patents - USPTO
  5. Patent Application Publication (10) Pub. No.: US 2006/0177512 - Google Patents

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 4,800,079

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
No data available in table
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 0 to 0 of 0 entries

International Family Members for US Patent 4,800,079

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Australia 601462 ⤷  Try for Free
Australia 7660387 ⤷  Try for Free
Austria 75940 ⤷  Try for Free
Canada 1293194 ⤷  Try for Free
Denmark 175867 ⤷  Try for Free
Denmark 411887 ⤷  Try for Free
Germany 3779009 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 7 of 7 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.